GAME [Shanda Games] 6-K: (Original Filing)

[Shanda Games Reports Fourth Quarter and Full Year 2013 Unaudited Results Hong Kong, China—March 21, 2014— (1) Fourth Quarter Non-GAAP Financial Highlights Ÿ Net revenues were RMB1,029.3 million (US$168.8 million), down 8.5% QoQ and 6.0% YoY. Ÿ Gross profit was RMB789.6 million (US$129.6 million), down 3.5% QoQ and 8.0% YoY. Gross margin was 76.7%, compared with 72.8% in Q3 2013] []

By | 2016-04-03T10:55:19+00:00 March 24th, 2014|Categories: Chinese Stocks, GAME, SEC Original|Tags: , , , , , |0 Comments

GAME [Shanda Games] 6-K: Shanda Games Reports Fourth Quarter and Full Year

[Shanda Games Reports Fourth Quarter and Full Year 2013 Unaudited Results Hong Kong, China—March 21, 2014— (1) Fourth Quarter Non-GAAP Financial Highlights Ÿ Net revenues were RMB1,029.3 million (US$168.8 million), down 8.5% QoQ and 6.0% YoY. Ÿ Gross profit was RMB789.6 million (US$129.6 million), down 3.5% QoQ and 8.0% YoY. Gross margin was 76.7%, compared with 72.8% in Q3 2013] []

By | 2016-04-03T10:56:13+00:00 March 24th, 2014|Categories: Chinese Stocks, GAME, Webplus ver|Tags: , , , , , |0 Comments

CTRP [CTRIP COM INTERNATIONAL] 6-K: Ctrip.com Swiftly Responds to Temporary Potential Internet Security

[Ctrip.com Swiftly Responds to Temporary Potential Internet Security Risk Shanghai, China, March 23, 2014, Ctrip.com International, Ltd. (NASDAQ: CTRP) (“Ctrip” or “the Company”), a leading travel service provider of hotel accommodations, ticketing services, packaged tours, and corporate travel management in China, today issued this press release in response to a recent incident related to Ctrip’s information security. In the evening] [CTRIP.COM INTERNATIONAL, LTD. 99 Fu Quan Road Shanghai 200335, People’s Republic of China Form 20-F x Form 40-F o o o CTRIP.COM INTERNATIONAL, LTD.]

By | 2016-03-31T10:59:30+00:00 March 24th, 2014|Categories: Chinese Stocks, CTRP, Webplus ver|Tags: , , , , , |0 Comments

TSL [Trina Solar] 6-K: (Original Filing)

[Trina Solar Announces Receipt of Favorable Arbitration Award and Adjusts Fourth Quarter and CHANGZHOU, China, March 20, 2014 — Trina Solar Limited (NYSE: TSL) (“Trina Solar” or the “Company”), a global leader in photovoltaic (“PV”) modules, solutions, and services, today announced it has received US$20.4 million from a customer in an arbitration settlement involving an outstanding account balance under a]

By | 2016-03-11T01:58:35+00:00 March 24th, 2014|Categories: Chinese Stocks, SEC Original, TSL|Tags: , , , , , |0 Comments

TSL [Trina Solar] 6-K: Trina Solar Announces Receipt of Favorable Arbitration Award

[Trina Solar Announces Receipt of Favorable Arbitration Award and Adjusts Fourth Quarter and CHANGZHOU, China, March 20, 2014 — Trina Solar Limited (NYSE: TSL) (“Trina Solar” or the “Company”), a global leader in photovoltaic (“PV”) modules, solutions, and services, today announced it has received US$20.4 million from a customer in an arbitration settlement involving an outstanding account balance under a]

By | 2016-03-11T01:59:27+00:00 March 24th, 2014|Categories: Chinese Stocks, TSL, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine — -Preclinical development completed for H7N9 vaccine candidates that addresses significant BEIJING, January 29, 2014—Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical Trial Application(CTA) with the China Food and Drug Administration(CFDA) to commence human clinical trials for] [Sinovac’s EV71 Vaccine Phase III Clinical Trial Results Published in New — Study shows vaccine provides protection against EV71-associated hand, foot and mouth th The New England Journal of Medicine BEIJING, Feb. 26, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that Phase III clinical trial results for its proprietary] [Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2013 BEIJING, March 12, 2014 — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and whole year ended December 31, 2013, after market closes on Wednesday, March 19, 2014] [Sinovac Reports Unaudited Fourth Quarter and Full Year 2013 Financial Results - Conference call scheduled for Thursday, March 20, 2014 at 8:00 AM EDT - BEIJING, March 19, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and full year financial results for the period ended December] []

By | 2016-03-16T07:25:26+00:00 March 24th, 2014|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

EJ [E-HOUSE (CHINA)] 6-K: (Original Filing)

[E-House and Tencent Announce Tencent’s Strategic Investment in Leju SHANGHAI/SHENZHEN, China, March 21, 2014 — E-House (China) Holdings Limited (“E-House”)(NYSE: EJ), a leading real estate services company in China, Leju Holdings Limited (“Leju”), a wholly-owned subsidiary of E-House and a leading provider of real estate online services, and Tencent Holdings Limited (“Tencent”, SEHK stock code: 00700), a leading provider of] [E-HOUSE (CHINA) HOLDINGS LIMITED Qiushi Building, 11/F No.383 Guangyan Road, Zhabei District Shanghai 200072 People’s Republic of China Form 20-F x Form 40-F o o o E-House (China) Holdings Limited]

SVA [SINOVAC BIOTECH] 6-K: Sinovac Files Clinical Trial Application with CFDA for

[Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine — -Preclinical development completed for H7N9 vaccine candidates that addresses significant BEIJING, January 29, 2014—Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical Trial Application(CTA) with the China Food and Drug Administration(CFDA) to commence human clinical trials for] [Sinovac’s EV71 Vaccine Phase III Clinical Trial Results Published in New — Study shows vaccine provides protection against EV71-associated hand, foot and mouth th The New England Journal of Medicine BEIJING, Feb. 26, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that Phase III clinical trial results for its proprietary] [Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2013 BEIJING, March 12, 2014 — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and whole year ended December 31, 2013, after market closes on Wednesday, March 19, 2014] [Sinovac Reports Unaudited Fourth Quarter and Full Year 2013 Financial Results - Conference call scheduled for Thursday, March 20, 2014 at 8:00 AM EDT - BEIJING, March 19, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and full year financial results for the period ended December] []

By | 2016-03-16T07:26:42+00:00 March 24th, 2014|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

GIGM [GIGAMEDIA] 6-K: (Original Filing)

[For further information contact: Brad Miller, Investor Relations Director Country/City Code 8862 Tel: 2656-8016 brad.miller@gigamedia.com.tw GigaMedia Preliminary 4Q13 Results in Line with Guidance 4Q Preliminary Results • Revenues of approximately $3.4 million, down 11 percent Q-o-Q, in line with the company’s guidance. The decrease reflected the end of operations in December of the game A.V.A. and a continued decline in] [For further information contact: Brad Miller, Investor Relations Director Country/City Code 8862 Tel: 2656-8016 brad.miller@gigamedia.com.tw GigaMedia Launches Mobile Game; First of Multiple New Strategic Growth Initiatives for 2014 Three Kingdoms Partner TAIPEI, Taiwan, March 5, 2014 – GigaMedia Limited (NASDAQ: GIGM) announced today that it released the mobile strategy card game The game launch is the first of several initiatives] [GIGAMEDIA LIMITED is submitting under cover of Form 6-K: 1. 2. GigaMedia Limited 6-K 1 d700550d6k.htm FORM 6-K]

Skip to toolbar